Chugai Pharmaceutical
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2018-07-26
- Valid until
- still holds
- Published
- 2018-07-25
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-09 · its source page states the value and the date
- Confidence
- 0.70
Sources
“July 26, 2018, Tokyo Japan – Preferred Networks, Inc. (PFN, Headquarters: Chiyoda-ku, Tokyo, President and CEO: Toru Nishikawa) has agreed to receive investments of about 700 million yen from Chugai Pharmaceutical Co., Ltd.”— what the page says, read 2026-11-09
Cite this claim
Plain text
AsOf. "Preferred Networks investment: Chugai Pharmaceutical", as of 2018-07-26. Claim clm_E65CCF0C0C46, https://asof.is/claim/clm_E65CCF0C0C46, accessed 2026-11-10. Source: https://www.preferred.jp/en/news/pr20181726.
APA
AsOf. (2018). Preferred Networks investment: Chugai Pharmaceutical (as of 2018-07-26) [Record clm_E65CCF0C0C46]. Retrieved November 10, 2026, from https://asof.is/claim/clm_E65CCF0C0C46 (source: https://www.preferred.jp/en/news/pr20181726)
BibTeX
@misc{asof_clm_E65CCF0C0C46,
author = {AsOf},
title = {Preferred Networks investment: Chugai Pharmaceutical},
year = {2018},
howpublished = {\url{https://asof.is/claim/clm_E65CCF0C0C46}},
note = {Claim clm\_E65CCF0C0C46, as of 2018-07-26; source: https://www.preferred.jp/en/news/pr20181726},
urldate = {2026-11-10}
}On the record
/claim/clm_E65CCF0C0C46.md/v1/claims/clm_E65CCF0C0C46submit a correction